Antero Midstream Corp (NYSE:AM) announced a quarterly dividend on Wednesday, July 10th, Zacks reports. Shareholders of record on Friday, July 26th will be paid a dividend of 0.308 per share by the pipeline company on Wednesday, August 7th. This represents a $1.23 annualized dividend and a dividend yield of 11.05%. The ex-dividend date of this dividend is Thursday, July 25th. This is a positive change from Antero Midstream’s previous quarterly dividend of $0.30.
Antero Midstream has increased its dividend payment by an average of 34.0% annually over the last three years and has raised its dividend annually for the last 3 consecutive years. Antero Midstream has a dividend payout ratio of 73.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Antero Midstream to earn $1.07 per share next year, which means the company may not be able to cover its $1.23 annual dividend with an expected future payout ratio of 115.0%.
Antero Midstream stock opened at $11.15 on Tuesday. Antero Midstream has a 52 week low of $10.12 and a 52 week high of $19.67. The business’s 50-day simple moving average is $11.79. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.99 and a current ratio of 0.99. The stock has a market capitalization of $5.57 billion, a PE ratio of 24.40, a price-to-earnings-growth ratio of 2.24 and a beta of 1.22.
In other Antero Midstream news, Director Yorktown Viii Associates Llc sold 1,825,600 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $12.61, for a total value of $23,020,816.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider K. Phil Yoo sold 20,000 shares of the stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $13.17, for a total transaction of $263,400.00. The disclosure for this sale can be found here.
AM has been the subject of several research reports. Barclays reissued a “buy” rating on shares of Ultragenyx Pharmaceutical in a research report on Thursday, May 9th. ValuEngine cut Vereit from a “buy” rating to a “hold” rating in a report on Friday. Raymond James began coverage on Solar Capital in a report on Tuesday, April 16th. They set an “outperform” rating and a $22.50 price target on the stock. Zacks Investment Research raised Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a report on Monday, July 8th. Finally, Citigroup set a $73.00 price target on Esperion Therapeutics and gave the company a “buy” rating in a report on Tuesday, May 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $26.11.
Antero Midstream Company Profile
Antero Midstream Corporation owns and operates midstream energy assets servicing rich gas production in North America. It owns and operates an integrated system of natural gas gathering pipelines, compression stations, processing and fractionation plants, and water handling and treatment assets in the Marcellus Shale and Utica Shale basins.
Featured Story: Golden Cross
Receive News & Ratings for Antero Midstream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antero Midstream and related companies with MarketBeat.com's FREE daily email newsletter.